Gastric Buttons Market Size, Share, Growth | Forecast 2028

The gastric buttons market size is expected to grow from US$ 400.0 million in 2022 to US$ 617.9 million by 2028; it is estimated to record a CAGR of 7.5% from 2022 to 2028.

The gastric buttons market is segmented based on offerings, applications, usage, end user, and geography. The report offers insights and in-depth analysis of the market, emphasizing various parameters such as dynamics, trends, and opportunities of the market and competitive landscape analysis of leading market players across various regions. It also includes an analysis of the impact of the COVID-19 pandemic across the regions.

Market Insights

Increasing Prevalence of Cancer, Neurological Disorders, Diabetes, and Gastrointestinal Diseases

Diabetes is a life-threatening chronic disease with no functional cure. Diabetes can lead to various complications in different body parts and increase the overall risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage are the major complications associated with diabetes. As there is a significant increase in diabetes cases worldwide, it results in life-changing complications among the population. According to the International Diabetes Federation (IDF), in 2017, 46 million diabetic patients were reported in North America, which is expected to reach 62 million in 2045.

Moreover, the data reported that ~425 million people had diabetes in 2017, which is expected to reach 629 million worldwide by 2045. The disease prevalence is expected to increase by ~35% during the forecast period. According to the Alzheimer's Association, in 2018, 5.7 million people had Alzheimer's disease in the Americas.

Cancer is a leading cause of death worldwide. According to the American Society of Clinical Oncology (ASCO), head and neck cancer accounts for ~4% of all cancers in the US. In 2020, ~562,328 individuals were diagnosed with head and neck cancer. Furthermore, in 2020, ~277,597 individuals worldwide died from the disease. Maintaining proper nutrition during cancer treatment is essential. When cancer patients struggle with nutrition, gastric buttons can help provide vitamins, minerals, calories, protein, and fluids required to help the patient fight infection, heal, and stay healthy during cancer treatment which is further expected to drive the growth of gastric buttons market.  

Neurological disorders such as Parkinson's disease, dementia, epilepsy and seizures, autism, cerebral palsy, and Alzheimer's disease affect the brain and nerves of the human body. In the US, the prevalence of neurological disorders is increasing. According to the Centers for Disease Control and Prevention (CDC), Alzheimer's disease is one of the top 10 leading causes of death in the US. In 2020, Alzheimer's disease affected 5.8 million people in the US. Similarly, according to the Parkinson's Foundation Prevalence Project, ~930,000 individuals with Parkinson's Disease were present in the US in 2020. Weight loss and malnutrition as suboptimal oral intake are common in patients with neurological disorders and are associated with increased disability, morbidity, and mortality.

Epilepsy is a noncommunicable chronic brain disease that affects people of all ages. According to the World Health Organization (WHO), around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases in the world. Almost 80% of people with epilepsy live in low- and middle-income countries. The same source estimates that up to 70% of people with epilepsy could live seizure-free with proper diagnosis and treatment. The nutritional management of patients with neurological disease is crucial, and enteral feeding is a commonly used method to provide nutritional support which is driving the growth of gastric buttons market.

Strategic Insights

A gastrointestinal disease affects the gastrointestinal (GI) tract, the passage that runs from the mouth to the anus. Common GI disorders include irritable bowel syndrome (IBS), acid reflux, indigestion, colon cancer, and hemorrhoids. According to the data published by International Foundation for Gastrointestinal Disorders, among all irritable bowel syndrome patients, ~40% of people have mild IBS, ~35% have moderate IBS, and ~25% have severe IBS. Certain factors such as food allergies, developing stages of gastroenteritis, sporadic colon movements, the abnormal composition of serotonin in the colon, and mild celiac disease are among the risk factors that cause irritable bowel syndrome. Pancreatic diseases, liver diseases, and inflammatory bowel diseases (IBDs) are often associated with nutritional difficulties and require adequate nutrition to support medical treatment. To overcome with nutritional difficulties among these diseases has increased the use of gastric buttons and driving the growth of gastric buttons market.

The gastrostomy button has recently been used as the enteral route of choice by many doctors and has the cosmetic advantage of being hidden under clothing. Once placed, it can be used for several days.

As chronic diseases are increasing faster, the adoption of the gastrostomy button for the administration of food and medicine has been progressing rapidly over the last five years, which is driving the gastric buttons market.

Offerings-Based Insights

Based on offerings, the gastric buttons market is bifurcated into product and accessories. In 2022, the product segment held the larger share of the market and is anticipated to register a higher CAGR during the forecast period. G-button is a skin-level low-profile device and can have either a mushroom or balloon tip as an internal bolster. Historically, G-tubes are primarily placed and subsequently replaced with G-buttons after 4–8 weeks when the tract has matured. This was later replaced by a primary G-button, which allows the placement of a low-profile device that can be untethered when patients do not require feeds. The G-button is a low-profiled gastrostomy replacement tube balloon catheter indicated for long-term use in a well-established gastrostomy tract or existing stoma for feeding and/or administration of medication or gastric decompression.

Gastric Buttons Market, by Offerings – 2022–2028

Get more information on this report : Request Free Sample PDF

Usage-Based Insights

Based on usage, the gastric buttons market is fragmented into enteral nutrition, medication, fluids, and others. In 2022, the enteral nutrition segment held the largest share of the market and is anticipated to register the highest CAGR during the forecast period. Enteral nutrition refers to any method of feeding that uses the gastrointestinal (GI) tract to deliver nutrition and calories. It can include a normal oral diet, the use of liquid supplements, or delivery by the use of a tube (tube feeding). According to the American College of Gastroenterology, there are six main types of feeding tubes—nasogastric tube, nasoduodenal tube, nasojejunal tube, gastrostomy tube, jejunostomy tube, and gastrojejunal tube. These tubes may have further subtypes depending on exactly where they end, the stomach or intestines. Enteral feeding is mainly used for patients suffering from stroke, cancer, gastrointestinal disorders, and neurological disorders to ensure proper nutrition for a better quality of life and higher chances of recovery. Therefore, increased use of enteral nutrition is expected to create demand for gastric buttons and drive the growth of gastric buttons market.

Application-Based Insights

Based on application, the gastric buttons market is bifurcated into children and adults. In 2022, the children segment held a larger share of the market and is anticipated to register a higher CAGR during the forecast period. Increase in preterm birth and surge in malnourishment among children in developing and underdeveloped economies are expected to drive the growth of gastric buttons market for the children segment over the forecast period.

End User-Based Insights

Based on end user, the gastric buttons market is segmented into hospitals, clinics, and others. The hospitals segment held the largest share of the market in 2022 and is expected to record the highest CAGR during the forecast period. The hospitals segment is expected to have lucrative growth opportunities in the next few years. Due to the higher number of patients getting admitted to hospitals, the hospital segment is estimated to grow rapidly during the forecast period.

The gastric buttons market players adopt organic strategies, such as product launch and expansion, to expand their footprint and product portfolio worldwide and meet the growing demand. Inorganic growth strategies witnessed in the market are partnerships and collaborations. These growth strategies have allowed the market players to expand their businesses and enhance their geographic presence. Additionally, acquisitions, partnerships, and other growth strategies help strengthen the company’s customer base and increase its product portfolio.

• In November 2022, HMC Group, the parent company of Medicina, announced MADCARE (89100 Sens – France) as a new partner in the distribution of its Medicina branded products in France. This partnership is expected to boost the sales of company products in the France market.
• In May 2021, QMD expanded its enteral feeding portfolio. QMD announced the addition of Nasogastric Tubes to the Degania Enteral Feeding Product Family. The Degania Nasogastric Tubes are manufactured from premium materials and designed to comply with ENFit connection standards for improved patient safety. The comprehensive product range includes several pediatric and adult designs.
• In March 2021, Applied Medical Technology, Inc. (AMT) announced the launch of a low-profile micro-G-JET. The micro-G-JET was designed to meet the enteral nutrition needs of pediatric patients. The new device is offered with gastric lengths of 0.8 cm to 2.5 cm and with jejunal lengths of 10 cm, 15 cm, 22 cm, and 30 cm.

Company Profiles

• Avanos Medical Inc
• Medicina Ltd
• danumed Medizintechnik GmbH
• Boston Scientific Corp
• QMD
• Nutricia Ltd
• Shin-Etsu Polymer Europe BV
• Applied Medical Technology Inc
• Fresenius Kabi AG
• Vygon (UK) Ltd